In this video, Aaron M. Drucker, MD, ScM, FRCPC, FAAD, discusses some of the new molecules coming for atopic dermatitis that ...

The FDA has approved the first proteolysis-targeting chimera for any oncologic indication. Vepdegestrant (Veppanu, Arvinas ...

BillionToOne, a molecular diagnostics company, announced the launch of a noninvasive test for pregnancies with high fetal ...

Once-weekly semaglutide was tied to a reduction in heavy drinking days among adults with obesity and alcohol use disorder, ...

In 2026, the biggest drivers of market trends in ophthalmology include rare diseases as well as gene therapies and AI, ...

Certain demographic and socioeconomic factors were associated with no-show rates for dermatology appointments, according to a ...

Nearly one-third of children with autism were diagnosed by a primary care provider, according to a study of Medicaid data ...

Most patients with systemic sclerosis require treatment with multiple modes of action, according to a presenter at Congress ...

Nicole B. Saphier, MD, has replaced Casey Means, MD, as the president’s nominee for surgeon general after months of a stalled ...

Having a birth plan in place was associated with improved maternal and neonatal outcomes, according to research presented at ...

Non-tobacco nicotine use before a positive pregnancy result increased the risk for pregnancy and delivery complications, ...

Digital eyestrain or computer vision syndrome is real, increasing in prevalence and severity, and is a causative factor in ...